Taken together these results suggest that oncogenic EML4-ALK activity orchestrates a transcriptional and post-transcriptional program to sustain the EMT phenotype in ALK-rearranged NSCLC. This evidence concerns the gene EML4 and non-small cell lung carcinoma.